LAB Standard Biotools Inc.
Industrials, filed as STANDARD BIOTOOLS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 Corvex Management sold out of Standard Biotools.
Who owns this now
Largest portfolio weights among holders, up to 0.1% (Andreas Halvorsen, Viking Global Investors). Not free-float ownership.
Who owns LAB
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| Andreas Halvorsen, Viking Global Investors | Hold | 58,651,170 | $48M | History | |
| Corvex Management exited 2026 Q2 Last 2026 Q1 | Exit 0.00% | 44,340 | $41K | History |
Insider trades
Open-market buys and sales by LAB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $14.4M bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Casdin Partners Master Fund, L.P. Director, +7 joint filersBuy$503K 350,000 shares at $1.44 +0.5% to stakeTraded Dec 2–4 Filed Dec 4, 2025
-
Casdin Partners Master Fund, L.P. Director, +7 joint filersBuy$10.1M 7,700,000 shares at $1.31 +12% to stakeTraded Nov 24–25 Filed Nov 26, 2025
-
Casdin Partners Master Fund, L.P. Director, +7 joint filersBuy$1.4M 1,075,000 shares at $1.28 +1.7% to stakeTraded Nov 18–20 Filed Nov 20, 2025
-
Casdin Partners Master Fund, L.P. Director, +7 joint filersBuy$1.1M 925,000 shares at $1.22 +1.5% to stakeTraded Nov 13–17 Filed Nov 17, 2025
-
Casdin Partners Master Fund, L.P. Director, +7 joint filersBuy$1.4M 1,175,000 shares at $1.17 +1.9% to stakeTraded Nov 7–12 Filed Nov 12, 2025
Also filed in the last 12 months, not counted as buying or selling: 16 share withholdings for taxes, 13 stock grants, and 2 option exercises.
Congress
No member of Congress reported trading LAB in the last three years. 1 member listed it in 2025 annual reports.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 424B3 | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 1.01,1.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K/A | 9.01 | Filing Doc | |
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| 8-K | 3.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 3.01 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $158.22M | $375.88M | $454.26M |
| Total non-current assets * | $164.85M | $236.46M | $113.49M |
| Total assets | $323.07M | $612.34M | $567.75M |
| Total current liabilities | $109.33M | $65.89M | $108.31M |
| Total non-current liabilities * | $50.54M | $74.73M | $35.16M |
| Total equity | -$148.05M | $471.72M | $424.29M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.